FDA issues EUA to baricitinib plus remdesivir for COVID-19
(HealthDay)—Emergency use authorization was issued for baricitinib in combination with remdesivir for hospitalized patients with COVID-19, the U.S. Food and Drug Administration announced Thursday.
Nov 20, 2020
1
5